Shandong Keyuan Pharmaceutical Co (SZSE:301281) Accounts Payable & Accrued Expense : ¥107.6 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Shandong Keyuan Pharmaceutical Co Accounts Payable & Accrued Expense?

Shandong Keyuan Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥93.1 Mil) to Dec. 2023 (¥93.9 Mil) and increased from Dec. 2023 (¥93.9 Mil) to Mar. 2024 (¥107.6 Mil).

Shandong Keyuan Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥93.5 Mil) to Dec. 2022 (¥88.2 Mil) but then increased from Dec. 2022 (¥88.2 Mil) to Dec. 2023 (¥93.9 Mil).

Shandong Keyuan Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shandong Keyuan Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Keyuan Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Shandong Keyuan Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

91.20

66.18

93.53

88.24

93.86

Shandong Keyuan Pharmaceutical Co Quarterly Data
	Dec13	Dec14	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial											95.50	87.80	93.15	93.86	107.56

Shandong Keyuan Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shandong Keyuan Pharmaceutical Co (SZSE:301281) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Keyuan Pharmaceutical Co Ltd (SZSE:301281) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601

Website

http://www.keyuanpharm.com

Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and their preparations.

Shandong Keyuan Pharmaceutical Co (SZSE:301281) Headlines

No Headlines